Covid-19 update: Moderna testing Omicron-specific Covid booster
Moderna has started testing an Omicron-specific Covid booster in healthy adults enrolling the first participant in a clinical trial.
Stay updated with breaking news from Pharmaceutical Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna has started testing an Omicron-specific Covid booster in healthy adults enrolling the first participant in a clinical trial.
While much progress has been made in some rare neurological diseases, others are only beginning to see interest from developers.
The US saw 47.6% of all ESG job adverts in the three months ending November this year compared to 43.1% the same period in 2021
In this column, the author discusses the issues of the COVID-19 third wave peak in India, Omicron sub-variant, new drugs and the possible end of COVID-19 globally.
The global Covid death toll has passed 5.5 million, with a figure of 5,596,595 according to researchers at Johns Hopkins University.